WORXE Worlds Online Inc

MariMed Stages the ‘Boston 280E THC Party’ in Boston Harbor To Protest Unfair Cannabis Industry Tax Laws

MariMed Stages the ‘Boston 280E THC Party’ in Boston Harbor To Protest Unfair Cannabis Industry Tax Laws

Inspired by the Boston Tea Party’s 250th Anniversary, Company Management and Employees Dress in Colonial Outfits, Decry Unfair IRS Code 280E

NORWOOD, Mass., July 13, 2023 (GLOBE NEWSWIRE) -- Channeling the Boston Tea Party’s rebellious spirit while dressed in traditional colonial garb, MariMed executives and team members staged the ‘Boston 280E THC Party’ from a boat in Boston Harbor on July 12. In reenacting 1773’s “No taxation without representation” revolt, yesterday’s event protested Section 280E of the Internal Revenue Service Code. Section 280E burdens cannabis companies with paying significantly higher taxes than most U.S. businesses, often resulting in higher product prices for consumers. MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading Massachusetts-based cannabis company, surprised the crowds at Boston Harbor when they boarded the Liberty Star schooner, heaved cargo chests emblazoned with “WEED” overboard1 and chanted anti-280E slogans.

Section 280E is a prime example of the unique obstacles that legal cannabis businesses must navigate that significantly increase the cost of conducting business. When calculating their taxes, Section 280E prevents the deduction of ordinary business expenses associated with “trafficking” a Schedule 1 or 2 controlled substance. , yet cannabis remains classified as a federally illegal Schedule 1 controlled substance by the U.S. federal government, on par with heroin. Due to Section 280E, cannabis businesses pay much more in taxes than they would if it were repealed, according to .

As a Boston-based multi-state cannabis operator, MariMed protested in a way that would make the Company’s Patriot ancestors proud – by paying homage to the most famous tax protest in history during the year of the Boston Tea Party’s 250th anniversary. By shining a light on Section 280E’s negative financial impact on legal cannabis operators, MariMed hopes to effectuate policy change geared towards industry growth and advancement.

MariMed CEO and President Jon Levine said, “MariMed is among the most-sound financial companies in cannabis, with top-selling brands in the markets we serve. Our protest was less about us and more to provide a voice for the entire industry. Section 280E is unfair and hampers companies striving to make cannabis accessible for consumers and medical cannabis patients in all legal states. It should be repealed. Doing so would remove an obstacle to our mission to improve people’s lives every day through cannabis.”

Mr. Levine continued, “We applaud some of the states where we operate, including Massachusetts, Illinois and Maryland, plus the 17 others that have providing cannabis businesses relief from 280E.”



A growing number of U.S. Congressmen and women are aligned with MariMed’s take on 280E: “State-legal cannabis businesses are denied equal treatment under 280E,” said earlier this year, referencing it as “grotesquely unfair treatment” and urging his colleagues to “allow legal cannabis operations to deduct business expenses, just like any other industry.”

For more information, visit

______________

1 The natural wood, sustainable boxes tossed into the Boston Harbor were empty, floated on the surface, and pulled immediately from the harbor.

About MariMed

MariMed Inc., a multi-state cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions, and its values. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. Proprietary formulations created by the Company’s technicians are embedded in its top-selling and award-winning products and brands, including Betty's EddiesTM, Nature’s HeritageTM, InHouseTM, Bubby’s BakedTM, K FusionTM, Kalm FusionTM, and VibationsTM: High + Energy. For additional information, visit

Media Contact:

Gretchen Giles

Grasslands: A Journalism-Minded Agency

Company Contact:

Howard Schacter

Chief Communications Officer

Email:

Phone: (781) 277-0007

Investor Relations Contact:

Steve West

Vice President, Investor Relations

Email:

Phone: (781) 277-0007



EN
13/07/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Worlds Online Inc

 PRESS RELEASE

MariMed Extends Series B Preferred Stock Obligation Through 2031, Stre...

MariMed Extends Series B Preferred Stock Obligation Through 2031, Strengthening Capital Structure NORWOOD, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today that it has entered into a Restructuring and Exchange Agreement (the “Agreement”) with the holders (the “Holders”) of its $14.725 million Series B Convertible Preferred Stock (the “Series B Obligation”). The restructuring extends the maturity of the Company’s obligations on favorable market term...

 PRESS RELEASE

MariMed Announces Fourth Quarter and Full Year 2025 Earnings Date

MariMed Announces Fourth Quarter and Full Year 2025 Earnings Date NORWOOD, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- . (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it will report its fourth quarter and full year 2025 financial results on March 11, 2026 after the markets close. Management will host a conference call on March 12, 2026 at 8:00 a.m. EDT to discuss financial results. A webcast will be available and can be accessed via MariMed’s Investor Relations website at . A playback of the call will...

 PRESS RELEASE

MariMed’s Betty’s Eddies™ Introduces New Limited-Edition Valentine’s S...

MariMed’s Betty’s Eddies™ Introduces New Limited-Edition Valentine’s Seasonal, Berry In Love Betty The Brand’s First-Ever Swirled Chew Combines Strawberry and Chocolate Flavors Plus CBG and Horny Goat Weed for Libido-enhancing Fun NORWOOD, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- ™, the all-natural cannabis fruit chews handcrafted for specific health and wellness effects, is expanding its lineup with a new limited-edition batch of strawberry chocolate chews in time for Valentine’s Day: Berry In Love Betty. Betty’s Eddies is one of the top-selling and award-winning brands developed and d...

 PRESS RELEASE

MariMed Launches Hemp-Derived THC Products Under its Vibations™ Brand ...

MariMed Launches Hemp-Derived THC Products Under its Vibations™ Brand in Rhode Island NORWOOD, Mass., Jan. 22, 2026 (GLOBE NEWSWIRE) -- (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, today announced the launch of a hemp-derived THC version of its hydrating drink mix brand in Rhode Island. The launch represents a capital-efficient opportunity for the Company to expand Vibations into the rapidly growing hemp THC beverage category through an established retail channel, without incremental cultivation or retail infrast...

 PRESS RELEASE

MariMed Statement on Historic Rescheduling of Cannabis

MariMed Statement on Historic Rescheduling of Cannabis NORWOOD, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator committed to improving lives every day, issued the following statement from CEO Jon Levine today. “We commend President Trump and the Trump Administration for reclassifying cannabis as a Schedule III drug. This is the single greatest cannabis reform in US history and will have far-reaching benefits for years to come. Most important, the reclassification means the Federal government officially a...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch